Evidence map›Paper›PMID 30603236›Full record

GuidelineDiabetology international2016

A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes-JDCP study 2.

Rimei Nishimura, Kazuo Izumi, Yasuaki Hayashino, Hideki Origasa, Mitsuhiko Noda, Kohjiro Ueki, Naoko Tajima

Abstract readPractice Guideline
In one paragraph

Guideline in Diabetology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Guideline
  5. Trial
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rimei NishimuraJapan Diabetes Society, Tokyo, Japan.
Kazuo IzumiJapan Diabetes Society, Tokyo, Japan.
Yasuaki HayashinoJapan Diabetes Society, Tokyo, Japan.
Hideki OrigasaJapan Diabetes Society, Tokyo, Japan.
Mitsuhiko NodaJapan Diabetes Society, Tokyo, Japan.
Kohjiro UekiJapan Diabetes Society, Tokyo, Japan.
Naoko TajimaJapan Diabetes Society, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The JDCP study is a large-scale, prospective observational study designed to elucidate risk factors for diabetic complications as they become manifest in Japanese type 1 and 2 diabetic patients in the course of their observation and follow-up. Of the 6338 patients enrolled in the study, all patients with type 1 diabetes (

Indexed as

Diabetic complicationsGlycemic controlJDCP studyNationwide observational studyType 1 diabetes

Identifiers

PMID30603236
PMCPMC6224906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.